Clinical Research

Participate in our clinical trials to access emerging treatments for mental health

Explore a new path in mental health.

At Mirabilis Health, we're advancing clinical research in psychedelic-assisted therapy for conditions like PTSD, depression, and anxiety.

“Receiving care from Mirabilis has been life-changing. They provided a safe, supportive space where I felt heard and understood. I’m truly grateful for their compassion and professionalism”
— 2024 Research participant
“Taking part in research at Mirabilis has been an exceptional experience from the start. The team is not only professional but deeply compassionate—fostering a sense of trust, understanding, and genuine care. From the moment I stepped through the door, I felt at ease, fully supported, and truly seen. It’s rare to find a place where the quality of service is matched by the warmth of human connection. In many ways, Mirabilis has felt like a home away from home.

In a world of questions, Mirabilis offered not just answers—but belonging.”
— Research participant
“During my time at Mirabilis Health, I received outstanding care and support from both the counselling team and the medical staff involved, in both 1 to 1 sessions and the clinical trial. The environment was professional, compassionate, sensitive, and I felt genuinely heard and respected throughout my treatment. The counsellors are highly skilled in working with PTSD and provided a safe space where I could begin to process trauma. The team overseeing the medical trial demonstrated exceptional diligence, empathy, and communication, ensuring I was fully informed and supported at every stage. Their combined efforts significantly contributed to moments of stability and peace, which I didn’t think was possible and I remain deeply grateful for their dedication and expertise. I will always be thankful for being involved and having the experiences.”
— research participant

Trials

  • IMPACT-1 Study investigating Methylone for PTSD

  • IMPACT-EXT Study investigating the long-term durability of Methylone as a treatment for PTSD

Completed/Currently Ongoing:

  • Generalised Anxiety Disorder:
    A study investigating the efficacy of Psilocybin plus psychological support in the treatment of severe Generalised Anxiety Disorder.
    Recruiting Q4 2025

  • Major Depressive Disorder:
    A study investigating the efficacy of Psilocin to treat Major Depressive Disorder.
    Recruiting Q4 2025

  • PTSD:
    A study investigating the efficacy and safety of a medicine to treat PTSD.
    Recruiting Q4 2025

Upcoming:

Further information:

  • Clinical trials can offer access to innovative new treatments before they’re widely available. While there’s no guarantee of personal benefit, many participants find the process valuable—sometimes life-changing.

    By taking part, you’re also helping to advance the science of mental health. Your involvement could pave the way for better treatments for others in the future.

  • We focus on therapies for trauma and mood-related conditions. Our most recent trial — IMPACT-1— was a randomised, double-blind, placebo-controlled Phase 2 study evaluating a a rapid-acting neuroplastogen developed by Transcend Therapeutics to treat PTSD.

    More studies are on the way—and we’re building a growing community of individuals and ready to be part of them.

  • Anyone living with a mental health condition interested in participating in research.

    We would like to hear from you if you:

    • Are living with PTSD, complex PTSD, depression, or anxiety.

    • Are aged 18 or older.

    • Live in Northern Ireland or the Republic of Ireland

    You don’t need to have tried therapy before, and you don’t need a diagnosis to register your interest. We’ll be in touch when new opportunities arise that may be a good fit for you.

    1. You’ll join our confidential research interest list.

    2. When a relevant trial opens, we’ll get in touch to see if you might be eligible.

    3. You’ll have the chance to ask questions, learn more, and decide whether to take part.

    If you’re not eligible for a particular study, we may contact you in future as new research opens up.

  • Every clinical trial we run is ethically approved and overseen by experienced clinicians, therapists, and researchers. Sessions are carefully monitored, with your wellbeing at the centre of every step.

    We are regulated by the RQIA and licensed by the Department of Health. 

Therapists and Mental Health Professionals

Are you a therapist, psychiatrist, or healthcare professional interested in psychedelic research? We’d love to hear from you. We’re growing our network of therapists to support current and future studies.

Please use our contact form to say hello and give us a brief background on your professional experience.

Register your interest in participating in a study